+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

GABA-ergic control of alpha-melanocyte-stimulating hormone (alpha-MSH) release by frog neurointermediate lobe in vitro



GABA-ergic control of alpha-melanocyte-stimulating hormone (alpha-MSH) release by frog neurointermediate lobe in vitro



Brain Research Bulletin 17(5): 717-723



Measurement of glutamate decarboxylase (GAD) activity in the intermediate lobe of the frog pituitary and brain showed that neurointermediate lobe extracts represented 12% of the GAD activity detected in the whole brain. No significant activity was measured in distal lobe extracts. Immunocytochemical studies revealed GAD-containing fibers among the parenchymal cells of the pars intermedia. The localization of GAD-like material in the intermediate lobe of the frog pituitary suggested a possible role of gamma-aminobutyric acid (GABA) in the regulation of melanotropic cell secretion. Administration of GABA (10(-6) to 10(-4) M), to perifused neurointermediate lobes caused a brief stimulation of alpha-melanocyte stimulating hormone (alpha-MSH) release followed by an inhibition. Picrotoxin (10(-4) M), a Cl- channel blocker, abolished only the stimulatory effect of GABA (10(-4) M), whereas bicuculline (10(-4) M), a specific antagonist of GABAA receptors, totally inhibited the effects of GABA (both stimulatory and inhibitory phases). Bicuculline induced by itself a slight stimulation of alpha-MSH release, suggesting that GABA-ergic nerve fibers present in the intermediate lobe are functionally active in vitro. The GABAA agonist muscimol (10(-7) to 10(-4) M) mimicked the biphasic effect of GABA on alpha-MSH release. Administration of baclofen, a specific GABAB agonist (10(-7) to 10(-4) M) induced a dose-dependent inhibition of alpha-MSH secretion. In contrast to GABA or muscimol, baclofen did not cause any stimulatory effect whatever the dose. Taken together these result suggested that GABAA and GABAB receptors were present on frog melanotrophs.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040189668

Download citation: RISBibTeXText

PMID: 3026578


Related references

Catecholaminergic control of alpha-melanocyte-stimulating hormone (alpha MSH) release by frog neurointermediate lobe in vitro: evidence for direct stimulation of alpha MSH release by thyrotropin-releasing hormone. Endocrinology 112(1): 133-141, 1983

Central-type benzodiazepines and the octadecaneuropeptide modulate the effects of GABA on the release of alpha-melanocyte-stimulating hormone from frog neurointermediate lobe in vitro. Neuroscience 31(2): 485-493, 1989

Gamma aminobutyric acid ergic control of alpha msh release by frog rana ridibunda neurointermediate lobe in vitro. Brain Research Bulletin 17(5): 717-724, 1986

In vitro study of frog (Rana ridibunda Pallas) neurointermediate lobe secretion by use of a simplified perifusion system. IV. Interaction between dopamine and thyrotropin-releasing hormone on alpha-melanocyte-stimulating hormone secretion. General and Comparative Endocrinology 64(3): 428-434, 1986

Structural studies of alpha-melanocyte-stimulating hormone and a novel beta-melanocyte-stimulating hormone from the neurointermediate lobe of the pituitary of the dogfish Squalus acanthias. Biochemical Journal 141(2): 439-444, 1974

Effect of serotonin on alpha-melanocyte-stimulating hormone secretion from perifused frog neurointermediate lobe: evidence for the presence of serotonin-containing cells in the frog pars intermedia. Journal of Endocrinology 122(1): 135-146, 1989

Incorporation of 14C-labelled amino acids into corticotrophin-like intermediate lobe peptide and alpha-melanocyte-stimulating hormone by the rat pituitary neurointermediate lobe in vitro, and the identification of four new pars intermedia peptides. Journal of Endocrinology 70(2): 197-205, 1976

Role of calcium in thyrotrophin-releasing hormone-stimulated release of melanocyte-stimulating hormone from frog neurointermediate lobe. Journal of Molecular Endocrinology 1(2): 131-139, 1988

Central type benzodiazepines and the octadecaneuropeptide modulate the effects of gaba on the release of alpha msh from frog neurointermediate lobe in vitro. Neuroscience 31(2): 485-494, 1989

Adrenergic control of alpha-melanocyte-stimulating hormone release in frog pituitary is mediated by both beta- and a nonconventional alpha 2-subtype of adrenoreceptors. Neuroendocrinology 61(4): 430-436, 1995

Alpha-latrotoxin stimulates secretion of melanocyte-stimulating hormone from the neurointermediate lobe of the lizard Anolis carolinensis. FASEB Journal 13(4 Part 1): A477, 1999

Alpha-melanocyte-stimulating hormone is a mammotrophic factor released by neurointermediate lobe cells after estrogen treatment. Endocrinology 130(1): 133-138, 1992

The major immuno reactive alpha melanocyte stimulating hormone like substance found in human fetal pituitary tissue is not alpha melanocyte stimulating hormone but may be deacetyl alpha melanocyte stimulating hormone acth 1 13 amide. Journal of Clinical Endocrinology & Metabolism 52(2): 319-323, 1981

Benzodiazepines and the octadecaneuropeptide odn modulate the effects of gaba on alpha msh release from frog neurointermediate lobe. General & Comparative Endocrinology 74(2): 301, 1989

Neuropeptide Y inhibits spontaneous alpha-melanocyte-stimulating hormone (alpha-MSH) release via a Y(5) receptor and suppresses thyrotropin-releasing hormone-induced alpha-MSH secretion via a Y(1) receptor in frog melanotrope cells. Endocrinology 143(5): 1686-1694, 2002